Sciencast Management LP Takes Position in Evoqua Water Technologies Corp (AQUA)

Share on StockTwits

Sciencast Management LP bought a new stake in shares of Evoqua Water Technologies Corp (NYSE:AQUA) during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund bought 15,300 shares of the company’s stock, valued at approximately $197,000.

A number of other institutional investors have also made changes to their positions in AQUA. Massachusetts Financial Services Co. MA raised its stake in shares of Evoqua Water Technologies by 127.4% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 3,147,867 shares of the company’s stock worth $30,219,000 after buying an additional 1,763,578 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of Evoqua Water Technologies by 34.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 5,392,610 shares of the company’s stock worth $95,880,000 after buying an additional 1,381,380 shares in the last quarter. Penn Capital Management Co. Inc. bought a new stake in shares of Evoqua Water Technologies in the 4th quarter worth $13,737,000. SG Capital Management LLC bought a new stake in shares of Evoqua Water Technologies in the 4th quarter worth $10,262,000. Finally, Amundi Pioneer Asset Management Inc. raised its stake in shares of Evoqua Water Technologies by 66.4% in the 4th quarter. Amundi Pioneer Asset Management Inc. now owns 2,011,118 shares of the company’s stock worth $19,307,000 after buying an additional 802,281 shares in the last quarter.

Shares of NYSE AQUA opened at $13.63 on Friday. Evoqua Water Technologies Corp has a 52-week low of $7.92 and a 52-week high of $22.91.

Evoqua Water Technologies (NYSE:AQUA) last issued its earnings results on Tuesday, February 5th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.01) by ($0.02). The company had revenue of $232.00 million during the quarter, compared to analyst estimates of $311.99 million. The firm’s revenue was down 20.3% on a year-over-year basis. During the same quarter last year, the firm earned ($0.03) EPS.

Separately, Goldman Sachs Group raised Evoqua Water Technologies from a “neutral” rating to a “buy” rating and set a $16.00 price objective on the stock in a research note on Tuesday, February 26th. Three analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus price target of $16.57.

WARNING: This piece was first published by Zolmax and is owned by of Zolmax. If you are accessing this piece on another domain, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this piece can be viewed at https://zolmax.com/investing/sciencast-management-lp-takes-position-in-evoqua-water-technologies-corp-aqua/3052673.html.

Evoqua Water Technologies Company Profile

Evoqua Water Technologies Corp. provides a range of water and wastewater treatment systems and technologies, and mobile and emergency water supply solutions and services. It operates in three segments: Industrial, Municipal, and Products. The Industrial segment offers capital systems and related recurring aftermarket services, parts, and consumables, as well as long-term and short-term service contracts, and emergency services for treating industrial process water, utility water, and wastewater.

Further Reading: Do You Need a Fiduciary?

Want to see what other hedge funds are holding AQUA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Evoqua Water Technologies Corp (NYSE:AQUA).

Institutional Ownership by Quarter for Evoqua Water Technologies (NYSE:AQUA)

Receive News & Ratings for Evoqua Water Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoqua Water Technologies and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Guaranty Federal Bancshares, Inc.  Given Average Recommendation of “Buy” by Brokerages
Guaranty Federal Bancshares, Inc. Given Average Recommendation of “Buy” by Brokerages
Central Valley Community Bancorp  Expected to Announce Earnings of $0.40 Per Share
Central Valley Community Bancorp Expected to Announce Earnings of $0.40 Per Share
-$1.20 EPS Expected for Catalyst Biosciences Inc  This Quarter
-$1.20 EPS Expected for Catalyst Biosciences Inc This Quarter
Brokerages Set $48.00 Target Price for Lydall, Inc.
Brokerages Set $48.00 Target Price for Lydall, Inc.
First Republic Bank  Earns “Outperform” Rating from Wedbush
First Republic Bank Earns “Outperform” Rating from Wedbush
Littelfuse  Cut to Sell at Zacks Investment Research
Littelfuse Cut to Sell at Zacks Investment Research


 
© 2006-2019 Zolmax.